Form 8-K REGENERON PHARMACEUTICAL For: Aug 05
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140805/AR2GG22CX222C2Z2222Q22NW4LHTZ2227262
Filed on: August 5, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission
- CloudShare v7 Solis AI Release: The Next Evolution of Simulated Virtual Environments for Sales Enablement and Hands-On Training
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
